Axe Compute Inc (AGPU) AI Stock Analysis

• Market Cap: $9.71M
• Dividend Yield: N/A
• Average Volume (3M): 173.82K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.83
• Revenue Growth: -47.20%
• EPS Growth: -163.70%
• Country: US
• Employees: 23
• Sector: Healthcare
• Sector Strength: 45
• Industry: Software - Infrastructure
• EPS (TTM): -107.25
• Shares Outstanding: 3,393,516
• 10 Day Avg. Volume: 72,596
• 30 Day Avg. Volume: 173,821
• PEG Ratio: 0.15
• Price to Book (P/B): -331.08
• Price to Sales (P/S): 41.31
• P/FCF Ratio: -5.61
• Enterprise Value/Market Cap: 1.16
• Enterprise Value/Revenue: 15.42
• Enterprise Value/Gross Profit: 30.69
• Enterprise Value/Ebitda: -0.14
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 43 Neutral
• Price Target: $3.00 ▼(-58.33% Downside)

The score is driven primarily by very weak financial performance (material revenue decline, severe losses, ongoing cash burn, and deeply negative equity). Technicals are also unfavorable due to a strong downtrend and negative momentum, despite oversold readings. Valuation provides limited support because the negative P/E reflects continued unprofitability and no dividend yield is available.

Positive Factors

Proprietary AI platform

A proprietary predictive analytics platform focused on tumor and treatment data creates sustainable competitive differentiation. Enduring IP and model datasets increase switching costs for partners, enabling recurring collaborations with pharma and research institutions over multiple development cycles.

Diverse revenue streams

Multiple commercialization channels—collaborations, licensing, lab services and provider alliances—reduce reliance on a single customer type. This diversification supports steadier bookings and repeatable long-term contracts from both industry and clinical partners, enhancing revenue durability.

Healthy product gross margins

A roughly 50% gross margin signals favorable unit economics for core services and models. If fixed costs are managed, high gross margins provide a path to scalable profitability as revenue stabilizes, making future margin expansion feasible once operating leverage kicks in.

Negative Factors

Steep revenue decline and losses

Material revenue deterioration coupled with outsized net losses undermines business resilience. Persistently negative margins indicate revenue isn't covering fixed costs, delaying breakeven and increasing the need for sustained external funding, which stresses long-term viability.

Deeply negative equity

Negative shareholders' equity is a structural capital shortfall reflecting cumulative losses. It restricts borrowing capacity, complicates strategic investments, and heightens dilution or restructuring risk; this materially increases the company's financing and solvency vulnerability over months.

Ongoing cash burn

Sustained negative operating and free cash flow forces reliance on external financing to maintain operations. Continued cash burn pressures strategic flexibility, raises refinancing risk, and can force cost-cutting that impairs growth initiatives and long-term product development timelines.

Axe Compute Inc Business Overview & Revenue Model

Company Description

Axe Compute Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of cancer therapies. It operates through two segments, Pittsburgh and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of 150,000+ tumor samples. This segment also creates proprietary 3D culture models used in drug development. Its Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. Predictive Oncology Inc. has a strategic collaboration with Every Cure to identify and prioritize drugs for repurposing. The company was formerly known as Predictive Oncology Inc. and changed its name to Axe Compute Inc. in December 2025. Axe Compute Inc. was incorporated in 2002 and is headquartered in Pittsburgh, Pennsylvania.

How the Company Makes Money

Predictive Oncology generates revenue through a combination of research collaborations, licensing agreements, and direct service offerings. Key revenue streams include partnerships with pharmaceutical companies and research institutions that utilize POAI's technology for drug development and clinical trials. The company also earns income by providing laboratory services for analyzing tumor samples and conducting predictive modeling. Additionally, strategic alliances with healthcare providers and participation in industry consortia further enhance its revenue potential by expanding the application of its predictive analytics in cancer treatment.

Axe Compute Inc Financial Statement Overview

Summary

Weak fundamentals: TTM revenue down ~32%, extremely large losses (TTM net margin roughly -116%), and ongoing negative operating/free cash flow (TTM FCF about -$8.8M). The balance sheet is a major concern with deeply negative stockholders’ equity (about -$77M), indicating elevated financial stability and funding risk despite relatively low absolute debt (~$1.9M).

Income Statement

Revenue has weakened materially in TTM (Trailing-Twelve-Months) (down ~32%), and profitability is extremely poor: while gross margin is ~50%, operating losses and net losses are outsized versus the revenue base (net margin roughly -116% in TTM). Annual results also show persistent losses with negative net margins across 2020–2024, suggesting the cost structure has not scaled with revenue and the business is not yet near breakeven.

Balance Sheet

The balance sheet has deteriorated sharply, with stockholders’ equity turning deeply negative in TTM (Trailing-Twelve-Months) (about -$77M), a major red flag for financial stability and funding risk. Total debt is relatively small in absolute terms (~$1.9M in TTM), but negative equity makes leverage metrics hard to interpret and underscores that cumulative losses have overwhelmed the capital base compared with prior years when equity was positive (2021–2023).

Cash Flow

Cash generation remains weak with consistently negative operating cash flow and negative free cash flow across all periods shown, including TTM (Trailing-Twelve-Months) (about -$8.8M). There is some improvement versus 2024 (smaller cash burn in TTM), but free cash flow growth is still negative in TTM and the business continues to rely on external financing to sustain operations.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	728.20K	1.62M	1.63M	1.51M	1.42M	1.25M
Gross Profit	365.87K	797.68K	1.02M	1.00M	933.66K	805.08K
EBITDA	-83.09M	-10.24M	-11.87M	-13.95M	-12.13M	-11.46M
Net Income	-84.33M	-12.20M	-13.98M	-25.74M	-19.66M	-25.88M
Balance Sheet
Total Assets	3.14M	4.97M	14.42M	25.73M	43.77M	13.06M
Cash, Cash Equivalents and Short-Term Investments	181.67K	734.67K	8.73M	22.07M	28.20M	678.33K
Total Debt	1.89M	2.13M	2.73M	180.32K	879.33K	5.87M
Total Liabilities	80.57M	5.18M	6.15M	3.97M	3.51M	10.42M
Stockholders Equity	-77.43M	-202.61K	8.27M	21.77M	40.27M	2.64M
Cash Flow
Free Cash Flow	-8.78M	-11.97M	-13.21M	-12.85M	-13.17M	-12.62M
Operating Cash Flow	-8.78M	-11.96M	-13.19M	-12.37M	-12.21M	-12.26M
Investing Cash Flow	657.00K	22.49K	-302.37K	-475.70K	-10.61M	-167.46K
Financing Cash Flow	4.36M	3.94M	148.90K	6.72M	50.34M	12.95M

Axe Compute Inc Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 7.20
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AGPU, the sentiment is Negative. The current price of 7.2 is above the 20-day moving average (MA) of 5.65, above the 50-day MA of 5.87, and below the 200-day MA of 11.16, indicating a bearish trend. The MACD of -0.91 indicates Positive momentum. The RSI at 26.10 is Positive, neither overbought nor oversold. The STOCH value of 7.76 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AGPU.

Axe Compute Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EKSO	54 Neutral	$29.52M	-1.68	-85.01%	―	-16.59%	43.20%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
WOK	44 Neutral	$1.90M	-0.01	―	―	―	―
AGPU	43 Neutral	$9.71M	-0.02	―	―	-47.20%	-163.70%
GCTK	42 Neutral	$1.74M	>-0.01	―	―	―	60.83%
FEMY	41 Neutral	$31.85M	-0.72	-376.23%	―	63.53%	12.49%

Axe Compute Inc Corporate Events

Axe Compute announces multiple board and executive resignations

On January 15, 2026, Axe Compute Inc. announced that director Shawn Matthews resigned from the board effective that same day, while director Veena Rao submitted her resignation effective January 30, 2026. The company also reported that Chief Investment Officer Thomas McLaughlin resigned effective January 19, 2026, with all three departures stated as unrelated to any disagreements over the company’s operations, policies, or practices, suggesting an orderly leadership transition rather than a response to internal conflict.

The most recent analyst rating on (AGPU) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Axe Compute Inc stock, see the AGPU Stock Forecast page.